Poland· PL-100289486
Dacogen
A decitabine product containing decitabinum, registered in Poland by Janssen-Cilag International N.V.. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Decitabine is registered in 14 of 19 countries.
Countries holding a registration under ATC L01BC08 (decitabine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Decitabine · ATC L01BC08
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of decitabine costs, country by country.
Normalised to the WHO defined daily dose (6.43 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Decitabine · price per daily dose (6.43 mg)
USD · FX 28 Sept 2026
- CH Switzerland$137.43
The record
At a glance
URPL (Poland)- Active substance
- Decitabinum
- Manufacturer
- Janssen-Cilag International N.V.
- Country
- Poland (PL)
- ATC code
- L01BC08
- ATC class
- Decitabine
- Defined daily dose
- 6.43 mg, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991023003
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
112 interactions on record for decitabine.
Graded by severity as the source publishes them — 30 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Decitabine · interactions on record
112 records
- 30 severe
- 82 moderate
Most severe, free to view
- CladribineL01BB04severe
- Talimogene laherparepvecL01XL02severe
- Talimogen laherparepvecL01XX51severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Decitabine in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainDACOGEN 50 mg polvo para concentrado para solucion para perfusionJanssen-Cilag International N.V
- SwedenDACOGEN 50 mg Pulver till koncentrat till infusionsvätska, lösningJanssen-Cilag International NV
- FinlandDacogenJanssen-Cilag International NV
- BelgiumDacogen 50 mgJanssen-Cilag International
- IrelandDacogen 50 mg powder for concentrate for solution for infusionJanssen-Cilag International NV
- NorwayDacogenJanssen-Cilag International N.V.
- United KingdomDacogen 50mg powder for concentrate for solution for infusion vialsJanssen-Cilag Ltd
- SwitzerlandDacogen
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Decitabin Accord, Decitabine Ever Pharma
- Belgium · Decitabine Ever Pharma, Decitabine Hikma
- Bulgaria · Децитабин Ever Pharma
- Cyprus · Decitabine Accord, Decitabine Teva
- Denmark · Decitabin Teva, Decitabine "sandoz"
- Spain · Decitabina Accord, Decitabina Eugia
- Finland · Decitabine Ever Pharma
- United Kingdom (Northern Ireland) · Decitabine Hikma Farmacêutica (Portugal)
- Croatia · Decitabin Accord, Decitabine Ever Pharma
- Hungary · Decitabine Ever Pharma
- Ireland · Decitabine Accord, Decitabine Ever Pharma
- Iceland · Dacogen
- Italy · Decitabina Accord, Decitabina Aurobindo
- Liechtenstein · Dacogen
- Lithuania · Decitabine Accord, Decitabine Ever Pharma
- Latvia · Decitabine Ever Pharma
- Netherlands · Decitabine Ever Pharma, Decitabine Hikma
- Norway · Dacogen, Decitabin Teva
- Portugal · Decitabina Accord, Decitabina Eugia
- Romania · Decitabină Accord, Decitabină Sandoz
- Sweden · Decitabin Teva, Decitabine Accord
- Slovenia · Decitabin Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/40866749-bb1d-40a4-991f-1c4885e9b7f7 GET /v1/drugs/40866749-bb1d-40a4-991f-1c4885e9b7f7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania koncentratu roztworu do infuzji",
"source": "urpl",
"strength": "50 mg",
"packaging": "05909991023003 ¦ Rpz ¦ EU/1/12/792/001 ¦ 80670\n1 fiol. 20 ml",
"substance": "Decitabinum 50 mg",
"common_name": "Decitabinum",
"pl_product_id": "100289486",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about decitabine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.